These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2791565)

  • 1. Effect of cocarboxylase in dogs subjected to experimental septic shock.
    Lindenbaum GA; Larrieu AJ; Carroll SF; Kapusnick RA
    Crit Care Med; 1989 Oct; 17(10):1036-40. PubMed ID: 2791565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of cocarboxylase in the treatment of experimental myocardial infarction in dogs.
    Larrieu AJ; Yazdanfar S; Redovan E; Eftychiadis A; Kao R; Silver J; Ghosh SC
    Am Surg; 1987 Dec; 53(12):721-5. PubMed ID: 3425997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of naloxone therapy on hemodynamics and metabolism following a superlethal dosage of Escherichia coli endotoxin in dogs.
    Raymond RM; Harkema JM; Stoffs WV; Emerson TE
    Surg Gynecol Obstet; 1981 Feb; 152(2):159-62. PubMed ID: 6782687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dichloroacetate administration in the treatment of endotoxin shock.
    Preiser JC; Moulart D; Vincent JL
    Circ Shock; 1990 Mar; 30(3):221-8. PubMed ID: 2178797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of assisted circulation in the management of endotoxic shock.
    Dunn JM; Kirsh MM; Harness J; Lee R; Straker J; Sloan H
    Ann Thorac Surg; 1974 Jun; 17(6):575-83. PubMed ID: 4601958
    [No Abstract]   [Full Text] [Related]  

  • 6. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study.
    Rank N; Michel C; Haertel C; Lenhart A; Welte M; Meier-Hellmann A; Spies C
    Crit Care Med; 2000 Dec; 28(12):3799-807. PubMed ID: 11153617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial metabolism during endotoxic shock.
    Scott JC; Weng JT; Spitzer JJ
    Adv Exp Med Biol; 1972; 33(0):375-86. PubMed ID: 4671943
    [No Abstract]   [Full Text] [Related]  

  • 8. Diltiazem treatment in newborn canine endotoxic shock.
    Goto M; Griffin AJ
    Jpn Heart J; 1990 Nov; 31(6):857-66. PubMed ID: 2084281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue increases myocardial function in septic shock.
    Daemen-Gubbels CR; Groeneveld PH; Groeneveld AB; van Kamp GJ; Bronsveld W; Thijs LG
    Crit Care Med; 1995 Aug; 23(8):1363-70. PubMed ID: 7634806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular response in canine endotoxic shock: effect of ibuprofen pretreatment.
    Pinsky MR
    Circ Shock; 1992 Aug; 37(4):323-32. PubMed ID: 1446391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic response to endotoxin in Escherichia coli-resistant animals.
    Tsagaris T; Hainer J; Waisbren B; Lange RL
    Am J Physiol; 1969 Feb; 216(2):271-5. PubMed ID: 4886098
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic vascular performance in endotoxic shock.
    Seyfer AE; Zajtchuk R; Hazlett DR; Mologne LA
    Surg Gynecol Obstet; 1977 Sep; 145(3):401-7. PubMed ID: 329452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of coenzyme Q10 on endotoxin shock in dogs.
    Yasumoto K; Inada Y
    Crit Care Med; 1986 Jun; 14(6):570-4. PubMed ID: 3709197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and muscle oxygen uptake/delivery after dopexamine infusion in endotoxic dogs.
    Bredle DL; Cain SM
    Crit Care Med; 1991 Feb; 19(2):198-204. PubMed ID: 1671210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of defective cardiac oxidative metabolism in intact dogs subjected to a prolonged low-dose infusion of Escherichia coli endotoxin.
    D'Orio V; el Allaf D; Vaira S; Fossion A; Juchmes J; Marcelle R
    Circ Shock; 1986; 18(1):43-52. PubMed ID: 3080258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dibutyryl cyclic AMP on hemodynamics and chemical mediators in dogs with experimentally-induced endotoxic shock.
    Okano S; Tagawa M; Urakawa N; Ogawa R
    J Vet Med Sci; 1993 Dec; 55(6):1001-4. PubMed ID: 8117795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of continuous norepinephrine infusion in dogs with and without hyperkinetic endotoxic shock.
    Melchior JC; Pinaud M; Blanloeil Y; Bourreli B; Potel G; Souron R
    Crit Care Med; 1987 Jul; 15(7):687-91. PubMed ID: 3297492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
    Grover R; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL
    Crit Care Med; 1999 May; 27(5):913-22. PubMed ID: 10362413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of slow intravenous endotoxin infusion on hemodynamics and survival in dogs.
    Emerson TE; Gill CC
    J Appl Physiol; 1967 May; 22(5):874-7. PubMed ID: 6026507
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
    Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
    Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.